↓ Skip to main content

Evaluation of an early step-down strategy from intravenous anidulafungin to oral azole therapy for the treatment of candidemia and other forms of invasive candidiasis: results from an open-label trial

Overview of attention for article published in BMC Infectious Diseases, February 2014
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (87th percentile)
  • High Attention Score compared to outputs of the same age and source (92nd percentile)

Citations

dimensions_citation
73 Dimensions

Readers on

mendeley
92 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Evaluation of an early step-down strategy from intravenous anidulafungin to oral azole therapy for the treatment of candidemia and other forms of invasive candidiasis: results from an open-label trial
Published in
BMC Infectious Diseases, February 2014
DOI 10.1186/1471-2334-14-97
Pubmed ID
Authors

Jose Vazquez, Annette C Reboli, Peter G Pappas, Thomas F Patterson, John Reinhardt, Peter Chin-Hong, Ellis Tobin, Daniel H Kett, Pinaki Biswas, Robert Swanson

Abstract

Hospitalized patients are at increased risk for candidemia and invasive candidiasis (C/IC). Improved therapeutic regimens with enhanced clinical and pharmacoeconomic outcomes utilizing existing antifungal agents are still needed.

Twitter Demographics

The data shown below were collected from the profile of 1 tweeter who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 92 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Spain 1 1%
Unknown 91 99%

Demographic breakdown

Readers by professional status Count As %
Researcher 18 20%
Student > Ph. D. Student 10 11%
Student > Bachelor 10 11%
Other 8 9%
Student > Postgraduate 7 8%
Other 24 26%
Unknown 15 16%
Readers by discipline Count As %
Medicine and Dentistry 46 50%
Pharmacology, Toxicology and Pharmaceutical Science 9 10%
Agricultural and Biological Sciences 5 5%
Immunology and Microbiology 4 4%
Biochemistry, Genetics and Molecular Biology 3 3%
Other 8 9%
Unknown 17 18%

Attention Score in Context

This research output has an Altmetric Attention Score of 11. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 December 2017.
All research outputs
#1,233,675
of 12,253,439 outputs
Outputs from BMC Infectious Diseases
#416
of 4,513 outputs
Outputs of similar age
#25,239
of 211,672 outputs
Outputs of similar age from BMC Infectious Diseases
#11
of 150 outputs
Altmetric has tracked 12,253,439 research outputs across all sources so far. Compared to these this one has done well and is in the 89th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 4,513 research outputs from this source. They receive a mean Attention Score of 4.7. This one has done particularly well, scoring higher than 90% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 211,672 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 87% of its contemporaries.
We're also able to compare this research output to 150 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 92% of its contemporaries.